Sustained in-vivo release of triptorelin acetate from a biodegradable silica depot: Comparison to Pamorelin® LA
Loading...
Access rights
openAccess
URL
Journal Title
Journal ISSN
Volume Title
A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Other link related to publication (opens in new window)
Date
2021-06-16
Major/Subject
Mcode
Degree programme
Language
en
Pages
14
Series
Nanomaterials, Volume 11, issue 6
Abstract
Triptorelin acetate was encapsulated into silica microparticles by spray-drying a mixture of colloidal silica sol and triptorelin acetate solution. The resulting microparticles were then combined with another silica sol containing silica nanoparticles, which together formed an injectable silica-triptorelin acetate depot. The particle size and surface morphology of the silica-triptorelin acetate microparticles were characterized together with the in vitro release of triptorelin, injectability and rheology of the final injectable silica-triptorelin acetate depot. In vivo pharmacokinetics and pharmacodynamics of the silica-triptorelin acetate depot and Pamorelin® were evaluated and compared in Sprague-Dawley male rats after subcutaneous administration. Serum samples up to 91 days were collected and the plasma concentrations of triptorelin and testosterone were analyzed with ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). In vivo pharmacokinetics showed that injections of the silica-triptorelin acetate depot gave 5-fold lower Cmax values than the corresponding Pamorelin® injections. The depot also showed a comparable sustained triptorelin release and equivalent pharmacodynamic effect as the Pamorelin® injections. Detectable triptorelin plasma concentrations were seen with the depot after the 91-day study period and testosterone plasma concentrations remained below the human castration limit for the same period.Description
Funding Information: Funding: Funding support from Ferring Pharmaceutical A/S is acknowledged. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
Controlled release, Silica hydrogel, Silica microparticles, Silica nanoparticles, Triptorelin
Other note
Citation
Forsback , A-P , Noppari , P , Viljanen , J , Mikkola , J , Jokinen , M , Leino , L , Bjerregaard , S , Borglin , C & Halliday , J 2021 , ' Sustained in-vivo release of triptorelin acetate from a biodegradable silica depot: Comparison to Pamorelin® LA ' , Nanomaterials , vol. 11 , no. 6 , 1578 . https://doi.org/10.3390/nano11061578